Juncture Wealth Strategies »

Neurocrine Biosciences shares owned by Juncture Wealth Strategies

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Juncture Wealth Strategies from 13F filings

Historical chart of Juncture Wealth Strategies investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Juncture Wealth Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Juncture Wealth Strategies

Quarter filed Position value Share count Share price at filing
2024-12-31 $994k 7.3k 136.50
2024-09-30 $968k 8.4k 115.22
2024-06-30 $1.2M 8.6k 137.67
2024-03-31 $1.2M 8.4k 137.92
2023-12-31 $1.1M 8.1k 131.76

More positions owned by Juncture Wealth Strategies

Vanguard Index Fds Large Cap Etf (VV)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Global X Fds S&p 500 Covered (XYLD)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Global X Fds Global X Uranium (URA)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Vanguard Index Fds Sml Cp Grw Etf (VBK)

View all positions for Juncture Wealth Strategies

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Bellevue Group
Geode Capital Management
Citadel Advisors
AQR Capital Management
T. Rowe Price Associates
Jpmorgan Chase & Co
Deerfield Management Company
Dodge & Cox
Goldman Sachs Group
DSM Capital Partners
Brown Advisory Holdings Incorporated

View all funds holding Neurocrine Biosciences